Assistant Professor of Global Health at Georgetown University’s School of Nursing & Health Studies, and Director of the Global Health Policy & Politics Initiative at the O’Neill Institute for National and Global Health LawGeorgetown University Medical Center
Political Economy of Development, Human Rights, Comparative Politics of Health, Health Policy
Matthew Kavanagh is a visiting professor at Georgetown University Law Center and director of the Global Health Policy and Governance Initiative at the O’Neill Institute. A political scientist by training, with extensive policy experience, he works at the intersection of global health, law, and political economy. Dr. Kavanagh’s research and policy work focus on the drivers of access to healthcare and medicines in low- and middle-income countries and the impact of human rights and constitutional protections on health outcomes. He currently serves on the Scientific and Technical Advisory Committee for UNAIDS, as an advisor to the Health Global Access Project, and has previously advised the WHO, U.S. State Department, and various NGOs on human rights and global health policy. As a social scientist, Dr. Kavanagh uses both qualitative research methods and large-N statistics to understand how governance institutions help or hinder the advancement of population health – with recent empirical fieldwork in South Africa, India, Malawi, Lesotho, and Thailand as part of projects on HIV treatment policy and the constitutionalization of health. His policy work seeks to address these governance challenges and has included leading transnational efforts focused on access to HIV treatment, community participation in global health programs, international trade, financial industry regulation, and water rights. This work has included drafting legislation introduced in the U.S. House of Representatives; presenting before the U.N. Special Rapporteur for the Right to Health, members of the Senate Foreign Relations Committee, House Ways and Means Committee, and the U.S. Trade Representative; and leading a successful policy change effort that secured expanded HIV treatment access in East and Southern Africa. Dr. Kavanagh’s work has appeared in a social science and health journals such as The Lancet, Studies in Comparative International Development, Health & Human Rights, and others and he has been interviewed in outlets ranging from the New York Times and Wall Street Journal to the BBC and Al Jazeera. He completed a PhD in political science from the University of Pennsylvania, certificate in health law from Penn’s law school, Masters in communities and policy from Harvard University and BA from Vassar College.
Dr. Keeley is the senior faculty member in the area of Interpersonal Communication. In the classroom, she encourages and challenges students to look at their own communication and to use pragmatic, theoretical, and scholarly knowledge to improve their lives and their relationships. Her courses include upper division Undergraduate courses and Master’s level courses in: Nonverbal Communication, Relational Communication, Family Communication, End-of-Life Communication, Interpersonal Communication, and Relational Health Communication. Dr. Keeley is an applied communication researcher that focuses on the communication that occurs within close relationships in the midst of difficult situations. She utilizes theory to describe and explain the communication that focuses on health and/or relational challenges revealing the verbal and nonverbal messages that help people to gain meaning, grow, heal, and connect more fully with one another in the midst of strong emotions and life changes. The practical applications of her research make a real difference in people’s everyday lives. She is nationally recognized as one of the leading researchers on relational communication at the end of life. The nature of Dr. Keeley’s research calls primarily for the use of qualitative methodologies. Dr. Keeley comes from a family filled with civil servants (police officers, fire fighters, and nurses) that placed a high value on helping and serving others. Her family’s values inspires Dr. Keeley to serve others by providing workshops for members of the community on final conversations, nonverbal, relational, and gender communication; she is active as a reviewer for numerous national and regional academic journals; and she is committed to meeting the needs of her department, college, and university.
How do you talk to kids about what’s going on with our planet and how they can make a difference? Peg Keiner, Director of Innovation at GEMS World Academy and the United Nations Ambassador for Chicago – Life on Land, is an expert when it comes to educating kids about the environments surrounding them, taking them right to the source to do so. Through field studies, exploration of nature preserves, and attending the climate march, Peg and her students are putting into action what they’ve been learning in the classroom. Peg is a National Geographic Education Fellow, a National Geographic Grosvenor Teacher Fellow, Apple Distinguished Educator, and a Google Earth Education Expert with over 15 years of teaching experience. She can offer informative and engaging ways to discuss with children what’s going on with our environment, and some easy ways for kids to make a real difference right in their neighborhood.
Clinical Physical Therapist, CDEAssociation of Diabetes Care & Education Specialists (ADCES)
Diabetes, Diabetes & Endocrinology, Diabetes and Adults, Type 2 Diabetes, Type 1 Diabetes, Insulin, Diabetes Management, Diabetes Self-management, Exercise, Diabetes and exercise
Kurtis Kim, M.D., is Director of The Vascular Laboratory at The Vascular Center at Mercy and a highly skilled vascular surgeon in the Baltimore area. He is Board Certified in Vascular Surgery and is a Registered Physician in Vascular Interpretation (RPVI). Dr. Kim is fluent in English and Korean. Dr. Kurtis Kim combines medical expertise with a caring approach to diagnose and treat patients with circulatory issues including leg pain and swelling and blood clots in legs and lungs. Patients appreciate and value the friendly and warm support they experience in Dr. Kim’s care. Dr. Kurtis Kim specializes in varicose vein removal and is experienced in the newest, non-invasive surgical methods including Venefit™ (formerly known as VNUS Closure™) and Veingogh© procedures. These treatments are minimally invasive and in many cases allow for faster recovery from varicose vein removal. Dr. Kim also performs minimally invasive surgeries such as balloon angioplasty, stent insertion, abdominal and aortic aneurysm repair and catheter procedures to unblock blood vessels. As Director of Mercy's nationally accredited Vascular Laboratory, Dr. Kurtis Kim oversees a wide variety of diagnostic tests and screenings to identify and monitor vascular disease. The clinical team of The Vascular Center at Mercy provides screenings for disorders including stroke and mini-stroke, poor circulation, leg swelling or pain and blockages. All lab technicians are nationally registered and experienced in circulatory screenings and the use of non-invasive ultrasound and Doppler Ultrasound equipment.
Assistant ProfessorUniversity at Albany, State University of New York
Information Security, Cybersecurity, digital forensics, Security
Dr. Kisekka is an assistant professor in the Department of Information Security and Digital Forensics. She earned her doctoral degree from the University at Buffalo’s School of Management, where she received the “PhD Student Achievement Award."She is also a recipient of the Pacesetter Award from Argonne National Lab, for her research contributions in Information Security. Dr. Kisekka teaches Security Risk Analysis, Security Policies, and Fraud Detection. Dr. Kisekka has published her research in high quality information systems journals and has also presented at several conferences and workshops such as the International Conference on Information Systems and the Americas Conference on Information Systems. Her research interests areas are: 1) Information security and privacy, where she studies users’ online security behaviors, and employees’ security behaviors. 2) Health information technologies, specifically, improving the utility of HITs for patients. 3.) A relatively new research area is communication on social media, specifically, the spread of information and misinformation. Dr. Kisekka employs both qualitative and quantitative methodologies in her research. Prior to earning a doctoral degree, Dr. Kisekka worked as a software consultant, working on projects for big companies such as Pfizer and Diageo. She has since gained extensive hands-on experience in the area of information security from working at Argonne National Lab, and managing a digital forensics lab at the University at Buffalo. Her work has been recognized outside of academia by news media such as Spotlight News and the Albany Business Review.
Professor of Medicine in the Division of InfectiouUniversity of California, Los Angeles (UCLA), Health Sciences
Sexually Transmitted Disease, STI, HIV, AIDS, Public Health, Global Health, Infectious Disease
Knott's research examines the optimal environment and policies (economic, industrial and firm) for innovation, and is best summarized in her book, How Innovation Really Works (March 2017). This interest stems from issues arising during an earlier career in defense electronics at Hughes Aircraft Company.
Professor, Department of Microbiology, ImmunologyUniversity of California, Los Angeles (UCLA), Health Sciences
Adenosine, X Linked Diseases, Bubble Boy Disease, Sickle Cell Disease, Genetic Disease, Gene Editing, Gene Therapy, Stem Cell, Stem Cell Therapy
Donald B. Kohn, M.D., studies the biology of blood stem cells, which are located in the bone marrow and have two important properties: they can duplicate themselves and they can create all types of blood cells. Over the course of 30 years of research, Kohn has developed new clinical methods to treat genetic blood diseases using blood stem cells that have been modified to remove genetic mutations. Kohn’s blood stem cell gene therapy method collects some of a patient’s own blood stem cells and either adds a good copy of the defective gene or fixes the broken genes to eliminate disease-causing mutations. The patient then receives a transplant of their own corrected stem cells, which will ideally create an ongoing supply of healthy blood cells. Importantly, this method eliminates the risk of rejection associated with receiving a bone marrow transplant from a different person, meaning the patient doesn’t have to take a lifelong supply of anti-rejection drugs. Kohn’s clinical trials for adenosine deaminase-deficient severe combined immunodeficiency (also known as ADA-SCID or bubble baby disease), a condition where babies are born without an immune system and often don’t survive past the first two years of life, have cured more than 40 babies to date. Babies with the condition and their families have traveled to UCLA for this life-saving treatment from as far away as Lebanon and a new company was formed in 2016 to further develop the therapy and make it available at other centers and to more patients. Kohn is now applying similar blood stem cell gene therapy techniques in clinical trials for two other diseases. One of these diseases is X-linked chronic granulomatous disease, a rare inherited immunodeficiency disorder that prevents white blood cells from effectively killing foreign invaders such as bacteria, fungi or other microorganisms. If untreated, patients often succumb to chronic granulomatous disease within the first decades of life. The second disease is sickle cell disease, the most common inherited blood disorder in the United States. This disease causes abnormal ‘sickle-shaped’ red blood cells that block small blood vessels and do not provide the appropriate amount of oxygen to the body, resulting in debilitating pain and organ damage. Kohn’s clinical trial seeks to overcome or repair the genetic mutation that causes this devastating disease, which impacts millions worldwide. Kohn earned his bachelor’s and master’s degrees from the University of Illinois, Champaign-Urbana and his medical degree from the University of Wisconsin School Of Medicine. He completed a pediatric internship and residency in Wisconsin followed by a medical staff fellowship in the Lymphoid Malignancies Branch (formerly the Metabolism Branch) of the National Cancer Institute. Kohn began working on gene therapy as a fellow at the National Institutes of Health in 1985 and then began practicing as a pediatric bone marrow transplant physician at Children’s Hospital Los Angeles in 1987. While practicing at Children’s Hospital Los Angeles, he started his own lab focused on stem cell research and has continued this work, advancing new therapies from the lab to the clinic.
Dr. Kumar is a board-certified pediatrician with nearly 20 years of experience. He earned his Doctor of Medicine degree from Johns Hopkins University School of Medicine, where he also completed his internship and residency in pediatrics. Dr. Kumar is a fellow of the American Academy of Pediatrics and is active in the Maryland chapter of the organization.
Matti Kummu is assistant professor at Aalto University, Finland. His research focuses on global water and food issues, particularly assessing the future opportunities towards water-smart food production. The main focus of his research is the interaction between the human population and water resources. He has been working extensively on assessing the global water scarcity and how it has impacted on food production and availability. To ease the ever-growing pressure on water and land resources, They are working actively in quantifying the potential of different measures, such as diet change, food loss reduction, emerging non-meat protein sources, and yield gap closure, to sustainably increase the food availability globally. Finally, They work also on more local scale challenges and opportunities on water-energy-food nexus, particularly in the Southeast Asian context.
Sociology, Popular Culture, Political, War, Terrorism, Fiscal Crisis
Richard Lachmann is the author of "First Class Passengers on a Sinking Ship: Elite Politics and the Decline of Great Powers" (Verso 2020), which examines the decline of dominant economic and military powers in early modern Europe and the contemporary United States. He also is the author of "States and Power" (Polity 2010) and "What Is Historical Sociology?" (Polity 2013). He currently is researching media coverage and governmental commemoration of war deaths in the United States and Israel from the 1960s to the present.
Dr. Robert Lanford, PhD, is currently the Director of the Southwest National Primate Research Center, one of seven NIH National Primate Research Centers. He is a Scientist at the Texas Biomedical Research Institute and an Adjunct Professor at the University of Texas Health Science Center. Dr. Robert E. Lanford received a B.S. degree from the University of Texas at Arlington in 1974 and a Ph.D. in Virology from Baylor College of Medicine in 1979. He served as Assistant Professor at Baylor College of Medicine until 1984 when he moved to the Southwest Foundation for Biomedical Research (now Texas Biomedical Research Institute) to initiate programs on the use of nonhuman primates as models for human hepatitis infections. Dr. Lanford has published over 170 scientific papers and serves as a reviewer for several journals. His laboratory performs research on multiple hepatitis viruses HAV, HBV, HCV and GBV-B. One of the primary goals of his research program is to better understand the interactions of the virus with the host, and how these interactions influence either viral clearance or persistence and disease progression. His studies in the chimpanzee were the first to use total genome microarray analysis to examine viral-host interactions and the innate immune response to HCV. In collaboration with pharmaceutical companies, he has utilized the chimpanzee model of chronic HBV and HCV infections to evaluate efficacy of new antiviral therapies as the last preclinical step prior to human clinical trials. These studies contributed to the development of cocktails of antivirals that can now cure HCV infection in 12 weeks. Recently, Dr. Lanford has developed a primate model for liver cancer by the genetic engineering of primary baboon hepatocytes with activated baboon oncogenes and autologous transplantation of the cells to the liver of the immunocompetent hepatocyte donor. Efforts are ongoing in his laboratory to develop new nonhuman primate models for HBV research.
Aimee LaPointe Terosky, Ed.D., is an associate professor of educational leadership at Saint Joseph's University and the Director of the IDEPEL Doctoral Program. Dr. Terosky teaches courses in K-12 and Higher Education leadership at the doctoral and masters levels. Prior to her arriving at Saint Joseph's in January 2011, Dr. Terosky was an adjunct assistant professor of higher and postsecondary education at Teachers College, Columbia University, where she taught courses on teaching and learning and faculty development in postsecondary education settings. From 2006-2011, she also served as the assistant principal of Public School #334, The Anderson School in New York City, which received the 2007 New York City Blackboard Award for Outstanding Public Middle School. Areas of expertise: urban principals, faculty careers, women faculty advancement, K-12 and higher education teaching and learning